What happened?
NITI Aayog launched the Roadmap for Building India as a Leading Bioeconomy Powerhouse by 2035 on 16 July 2026. The roadmap treats biotechnology and biomanufacturing as major engines of India’s future economic and scientific growth.
Key facts
- The release says India’s bioeconomy grew from $10 billion in 2014 to $195.3 billion in 2025, contributing 4.8% to GDP.
- The roadmap targets growth to $691 billion by 2035 and $2.6 trillion by 2047.
- The official note says the strategy could create over 30 million high-value jobs.
- A major recommendation is the creation of six National BioMissions: GeneIndia, AgriBio 2.0, BioX Foundry, One Health Grid, Marine Biotechnology and BioPharmaNext.
- The roadmap emphasizes convergence between AI and biology, including biofoundries, digital twins, biosensor networks, robotics and AI-driven discovery platforms.
- It also proposes a Rs. 50,000 crore BioEconomy Growth Fund from within the existing Rs. 1 lakh crore RDI framework.
Why it matters
This topic matters because biotechnology is increasingly linked with health security, agriculture, climate solutions, industrial policy and high-value manufacturing. It is a strong example of how science policy is being connected to long-term development strategy.
Exam takeaway
Do not reduce bioeconomy to only pharma. In answers, connect it with biotechnology, agriculture, climate resilience, industrial biotechnology, biomanufacturing, AI integration and innovation-led growth.
Source metadata
Authority: Press Information Bureau, NITI Aayog
Publication date: 16 July 2026
Official source: https://www.pib.gov.in/PressReleasePage.aspx?PRID=2285858&lang=1®=48
Useful excerpt
Official source highlight: the roadmap says India’s bioeconomy reached $195.3 billion in 2025 and sets a pathway to $691 billion by 2035 through six National BioMissions and stronger biomanufacturing capacity.